Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial

Cancer Treat Rep. 1984 Oct;68(10):1295-6.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anthraquinones / adverse effects
  • Anthraquinones / therapeutic use*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Bronchogenic / drug therapy*
  • Drug Evaluation
  • Humans
  • Lung Neoplasms / drug therapy*
  • Mitoxantrone

Substances

  • Anthraquinones
  • Antineoplastic Agents
  • Mitoxantrone